K230852

Substantially Equivalent

HemosIL Chromogenic Factor IX

Applicant: Instrumentation Laboratory Company
Product code: GGP
Advisory panel: Hematology
Date received: 2023-03-28
Decision date: 2023-12-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bedford, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.